Full Text View
Tabular View
No Study Results Posted
Related Studies
Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion / (VMT) Including Macular Hole (OASIS)
This study is ongoing, but not recruiting participants.
Study NCT01429441   Information provided by ThromboGenics

First Received on September 2, 2011.   Last Updated on November 15, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Retinal Perforations
Tissue Adhesions
More general conditions related to this trial
Cicatrix
Eye Diseases
Fibrosis
Pathologic Processes
Retinal Diseases
Interventions listed in this trial
Ocriplasmin
Sham injection
Sponsors listed in this trial
ThromboGenics


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services